10x Genomics, Inc.
TXG
Ранг среди акций
#2229
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012... Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.
Цена акции
$69.74
Последняя синхронизация: 2026-10-16
Рыночная капитализация
$9.09B
Изменение (1 день)
-3.67%
Изменение (1 год)
489.48%
Страна
US
Торговля 10x Genomics, Inc. (TXG)
Категория
Healthcare
Операционная маржа для 10x Genomics, Inc. (TXG)
Операционная маржа на October 2026 TTM: -14.33%
Согласно последним финансовым отчетам и цене акций 10x Genomics, Inc., текущая операционная маржа (TTM) составляет -14.33%. В конце 2023 она составила -42.88%.
История операционной маржи 10x Genomics, Inc. с 2017 по 2026
Операционная маржа на конец каждого года
| Год | Операционная маржа | Изменить |
|---|---|---|
| 2026 (TTM) | -14.33% | -55.01% |
| 2024 | -31.85% | -25.72% |
| 2023 | -42.88% | 31.86% |
| 2022 | -32.52% | 201.39% |
| 2021 | -10.79% | -62.21% |
| 2020 | -28.55% | 141.54% |
| 2019 | -11.82% | -84.39% |
| 2018 | -75.70% | 192.84% |
| 2017 | -25.85% | 0.00% |
Операционная маржа для аналогичных компаний или конкурентов
| Компания | Операционная маржа | Разница в операционной марже | Страна |
|---|---|---|---|
| 12.70% | -100.89% |
US
|
|
| 74.94% | -105.23% |
AU
|
|
| 3.33% | -100.23% |
US
|
|
| -19.76% | -98.62% |
US
|
|
| 0.00% | - |
US
|
Что такое операционная маржа компании?
Операционная маржа — это ключевой показатель прибыльности компании. Более высокая операционная маржа обычно означает, что компания может продавать свои товары или услуги значительно дороже их себестоимости. Она рассчитывается путем деления прибыли компании на её выручку.